ANAB ▼ -0.5% - AnaptysBio, Inc. $ANAB - Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update AnaptysBio fell 0.5% following the release of its second quarter and transitional fiscal year 2026 financial results and business update. The modest decline suggests the earnings report and company guidance did not contain material positive catalysts sufficient to drive investor buying. 21-SEP-2026 04:15 PM ET